Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Analysis of risk factors for thromboembolism in patients with JAK2V617F gene mutation positive myeloproliferative neoplasms].

Zhonghua yi xue za zhi - 5 Dec 2023

Zhang Y H, Teng G S, Ma J Y, Hu X, Du C X, Wang Y, Hu N B, Li Y Q, Shao Z H, Bai J

Abstract excerpt

Objective: To analyze the risk factors of thrombosis in patients with JAK2V617F mutation positive myeloproliferative neoplasms (MPN). Methods: A total of 223 MPN patients with JAK2V617F mutation in the Second Hospital of Tianjin Medical University from September 2017 to May 2023 were retrospectively enrolled, including 111 males and 112 females, aged [M(Q1,Q3)] 57(21,66) years. According to the presence or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Janus Kinase 2
Share to Lymphotoxin-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myeloproliferative Disorders

Share to Polycythemia Vera

Share to Risk Factors

Share to Thromboembolism

Share to Thrombosis

Source

Identifiers

PMID: 38018064
DOI: 10.3760/cma.j.cn112137-20231007-00647

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Analysis of risk factors for thromboembolism in patients with JAK2V617F gene mutation positive myeloproliferative neoplasms].PMID 38018064Read ↗

Thrombosis among 1537 patients with JAK2V617F -mutated myeloproliferative neoplasms: Risk factors and development of a predictive model.Semantic proximity Read ↗

[Analysis of risk factors for venous thromboembolism in patients with polycythemia vera and establishment of a prediction model].Semantic proximity Read ↗

[Clinical Analysis of Gene Mutation and Vascular Events in Patients with BCR/ABL Negative Myeloproliferative Neoplasms].Semantic proximity Read ↗

Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.Semantic proximity Read ↗

Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms.Semantic proximity Read ↗

[Relationship between DTA Mutations and Thromboembolism in Patients with Myeloproliferative Neoplasms].Semantic proximity Read ↗

Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision OncologySemantic proximity Read ↗

JAK2 mutation-related disease and thrombosis.Semantic proximity Read ↗

Molecular and Clinical Risk Factors Associated with Thrombosis and Bleeding in Myelofibrosis Patients.Semantic proximity Read ↗

Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS scoreSemantic proximity Read ↗

Thrombosis-Driven Disease Progression in JAK2-Mutant Polycythemia Vera and Essential Thrombocythemia: Reassessing Risk-Based Management.Semantic proximity Read ↗

Thrombosis in primary myelofibrosis: incidence and risk factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.